190 related articles for article (PubMed ID: 38359998)
1. RNA therapeutics for metabolic disorders.
Vu TD; Lin SC; Wu CC; Chu DT
Prog Mol Biol Transl Sci; 2024; 203():181-196. PubMed ID: 38359998
[TBL] [Abstract][Full Text] [Related]
2. RNA therapeutics for disorders of excretory system.
Vu TD; Nguyen MA; Jurgoński A; Chu DT
Prog Mol Biol Transl Sci; 2024; 203():245-256. PubMed ID: 38360001
[TBL] [Abstract][Full Text] [Related]
3. Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases.
Holm A; Hansen SN; Klitgaard H; Kauppinen S
RNA Biol; 2022; 19(1):594-608. PubMed ID: 35482908
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis.
Niemietz C; Chandhok G; Schmidt H
Molecules; 2015 Sep; 20(10):17944-75. PubMed ID: 26437390
[TBL] [Abstract][Full Text] [Related]
5. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
6. Chemistry, structure and function of approved oligonucleotide therapeutics.
Egli M; Manoharan M
Nucleic Acids Res; 2023 Apr; 51(6):2529-2573. PubMed ID: 36881759
[TBL] [Abstract][Full Text] [Related]
7. Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran.
Titze-de-Almeida SS; Brandão PRP; Faber I; Titze-de-Almeida R
Mol Diagn Ther; 2020 Feb; 24(1):49-59. PubMed ID: 31701435
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin.
Gogate A; Belcourt J; Shah M; Wang AZ; Frankel A; Kolmel H; Chalon M; Stephen P; Kolli A; Tawfik SM; Jin J; Bahal R; Rasmussen TP; Manautou JE; Zhong XB
Pharmacol Rev; 2023 Dec; 76(1):49-89. PubMed ID: 37696583
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles and siRNA: A new era in therapeutics?
Pérez-Carrión MD; Posadas I; Ceña V
Pharmacol Res; 2024 Mar; 201():107102. PubMed ID: 38331236
[TBL] [Abstract][Full Text] [Related]
10. Re-Engineering RNA Molecules into Therapeutic Agents.
Egli M; Manoharan M
Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Oligonucleotide-Based Therapy for Transthyretin Amyloidosis: Clinical Impact and Future Prospects.
Hayashi Y; Jono H
Biol Pharm Bull; 2018; 41(12):1737-1744. PubMed ID: 30504675
[TBL] [Abstract][Full Text] [Related]
12. Treating hereditary transthyretin amyloidosis: Present & future challenges.
Echaniz-Laguna A; Cauquil C; Labeyrie C; Adams D
Rev Neurol (Paris); 2023; 179(1-2):30-34. PubMed ID: 36150937
[TBL] [Abstract][Full Text] [Related]
13. Progress on RNA-based therapeutics for genetic diseases.
Luo T; Huo C; Zhou T; Xie S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):406-416. PubMed ID: 37643975
[TBL] [Abstract][Full Text] [Related]
14. Development of siRNA Therapeutics for the Treatment of Liver Diseases.
Holm A; Løvendorf MB; Kauppinen S
Methods Mol Biol; 2021; 2282():57-75. PubMed ID: 33928570
[TBL] [Abstract][Full Text] [Related]
15. Novel RNA-targeted therapies for hereditary ATTR amyloidosis and their impact on the autonomic nervous system.
Conceição I
Clin Auton Res; 2019 Sep; 29(Suppl 1):11-17. PubMed ID: 31399774
[TBL] [Abstract][Full Text] [Related]
16. Advances in the treatment of hereditary transthyretin amyloidosis: A review.
Gertz MA; Mauermann ML; Grogan M; Coelho T
Brain Behav; 2019 Sep; 9(9):e01371. PubMed ID: 31368669
[TBL] [Abstract][Full Text] [Related]
17. Inotersen: First Global Approval.
Keam SJ
Drugs; 2018 Sep; 78(13):1371-1376. PubMed ID: 30120737
[TBL] [Abstract][Full Text] [Related]
18. Challenges and Opportunities for Nucleic Acid Therapeutics.
Corey DR; Damha MJ; Manoharan M
Nucleic Acid Ther; 2022 Feb; 32(1):8-13. PubMed ID: 34931905
[TBL] [Abstract][Full Text] [Related]
19. Delivery of RNA Therapeutics: The Great Endosomal Escape!
Dowdy SF; Setten RL; Cui XS; Jadhav SG
Nucleic Acid Ther; 2022 Oct; 32(5):361-368. PubMed ID: 35612432
[TBL] [Abstract][Full Text] [Related]
20. [Recent progress and prospect in oligonucleotide therapeutics].
Yoshioka K; Kuwahara H; Nishina K; Nagata T; Yokota T
Nihon Rinsho; 2015 Jun; 73(6):1057-65. PubMed ID: 26065142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
